Mankind Pharma shares extend gain on CCI nod for BSV acquisition
The CCI has cleared Mankind Pharma's proposed acquisition of 100% stake in Bharat Serums and Vaccines for ₹13,630 crore.
The CCI has cleared Mankind Pharma's proposed acquisition of 100% stake in Bharat Serums and Vaccines for ₹13,630 crore.
According to the CCI, AI's transformative capabilities hold significant potential for promoting competition
CCI mentioned that the Director General (DG) will continue with the investigation as per the commission's earlier order issued on March 15.
The Reserve Bank of India (RBI), the banking regulator, had previously issued a no-objection certificate (NOC) for the merger in October of last year.
Back in November of the previous year, Switzerland-based Zurich Insurance Group had agreed to acquire a 51% stake in KMGIC for approximately ₹4,051 crore.
JSW Group entered into a joint venture with China's SAIC Motor last year.
The Burman family, which owns FMCG major Dabur India, is currently the single largest shareholder in REL and holds around 21% stake through its four group entities.
The regulator has approved the acquisition of a majority stake in Indira IVF by Zonnebaars and the amalgamation of Spaceway Wellness into Indira IVF.
The CCI’s decision to allow HDFC to own over 50% stake in HDFC Life could be a positive for the insurance company as this removes the overhang of RoE dilution in the merged entity.
IAMAI is facing flak from Indian startups after it argued against the need for a separate digital competition law for Big Tech firms.